In addition, CLL with TP53 abnormalities are associated with higher genomic complexity than CLL without, and this may have additional adverse prognostic implications for poor outcomes such as unmutated IGHV status, del(17p) or del(11q)[12]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.